IL10 and graft versus host disease: IL-10 transduction has been exploited to generate murine bone marrow-derived IL-10-producing tolDC (34), and used to promote antigen-specific tolerance in vivo via Treg induction (35, 36), or to differentiate IL-10-producing Tr1 cells in vitro suitable for cell-based approaches in preclinical models of GvHD (37).